VisiOn Restoration With FluidVisION Accommodating Intraocular Lens (AIOL)
- Conditions
- Cataract
- Interventions
- Device: FluidVision AIOLProcedure: Cataract surgeryDevice: AcrySof IQ monofocal IOL
- Registration Number
- NCT03925545
- Lead Sponsor
- PowerVision
- Brief Summary
The objective of this study is to obtain an initial assessment of the safety and performance of an investigational AIOL in patients undergoing cataract extraction and IOL implantation.
- Detailed Description
This study was originally designed as a single arm, unilateral study (one eye, one product only) to obtain an initial assessment of the safety and performance of an investigational IOL in subjects undergoing cataract extraction and IOL implantation. The study design was later modified to a contralateral study (both eyes, different product in each eye) to compare the safety and performance of the investigational IOL to a commercially available monofocal IOL.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 85
- Corrected distance visual acuity (CDVA) worse than 20/40, or presence of visually significant lens opacity;
- Preoperative or predicted postoperative astigmatism of ≤ 1.0 diopter (D);
- Calculated IOL power within range.
Key
- Current medication that may affect accommodation;
- Systemic disease or concomitant medication that may increase operative risk or confound results;
- Ocular conditions that may predispose the subject for future complications;
- Monocular subjects or subjects with significant permanent visual function loss in fellow eye;
- Previous intraocular or corneal surgery in either eye that may confound the results or increase the risk to the subject, including implantation of a multifocal IOL or other presbyopic corrective surgery in the fellow eye;
- Grade 4 cataract of any type.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Unilateral FluidVision AIOL Implantation with the FluidVision AIOL in one eye during cataract surgery. Only one eye was treated. Unilateral Cataract surgery Implantation with the FluidVision AIOL in one eye during cataract surgery. Only one eye was treated. Contralateral AcrySof IQ monofocal IOL Implantation with the FluidVision AIOL in the first eye during cataract surgery, followed by implantation with the AcrySof IQ monofocal IOL in the fellow eye during a subsequent cataract surgery Contralateral Cataract surgery Implantation with the FluidVision AIOL in the first eye during cataract surgery, followed by implantation with the AcrySof IQ monofocal IOL in the fellow eye during a subsequent cataract surgery Contralateral FluidVision AIOL Implantation with the FluidVision AIOL in the first eye during cataract surgery, followed by implantation with the AcrySof IQ monofocal IOL in the fellow eye during a subsequent cataract surgery
- Primary Outcome Measures
Name Time Method Distance Corrected Visual Acuity Month 6 postoperative Visual acuity was measured with distance correction (plus or minus power) in place.
International Organization for Standardization (ISO)-defined Cumulative and Persistent Adverse Events for Posterior Chamber IOL Up to Month 6 postoperative Adverse events were categorized per ISO 11979-7: Ophthalmic Implants - Intraocular Lenses - Part 7: Clinical Investigations.
Accommodative Amplitude (AA) Month 6 postoperative Accommodative amplitude is the ability of the eye to change its focus from distant to near objects.
- Secondary Outcome Measures
Name Time Method Uncorrected Visual Acuity Up to Month 6 postoperative Visual acuity was measured without correction in place.
Minimum Add Power Required to Achieve Best Corrected Near Visual Acuity Up to Month 6 postoperative Plus lenses were placed over the subject's best distance manifest correction.
Accommodative Amplitude Month 3 postoperative Accommodative amplitude is a measure of the range of vision with good acuity.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.